FDA extends comment period regarding alternative name of potassium chloride
The U.S. Food and Drug Administration (FDA) is extending by 60 days, until September 17, 2019, the comment period on the draft guidance, “The Use of an Alternate Name for Potassium Chloride in Food Labeling.”
The U.S. Food and Drug Administration (FDA) is extending by 60 days, until Sept. 17, 2019, the comment period on the draft guidance, “The Use of an Alternate Name for Potassium Chloride in Food Labeling.” The original comment period was scheduled to end on July 19.
The agency is taking this action in response to requests for additional time to submit comments. The FDA believes that the extension will allow adequate time for interested persons to provide input.
Potassium chloride, in some instances, can be used as a partial substitute for sodium chloride in food processing and manufacturing. The addition of the term “salt” to “potassium chloride” may encourage manufacturers to use this sodium alternative and help consumers to understand that potassium chloride can replace sodium chloride in foods. This may help to reduce the intake of sodium, which is over-consumed by the U.S. population, while increasing potassium, which is under-consumed.